Michael B Streiff, Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Tyler Buckner, Robert Diep, Kleber Yotsumoto Fertrin, Annemarie E Fogerty, Nicolas Gallastegui Crestani, Radhika Gangaraju, Cristhiam Rojas-Hernandez, Samuel Z Goldhaber, Ibrahim Ibrahim, Timothy Kubal, Andrew D Leavitt, Ming Lim, Janelle Mann, Simon Mantha, Colleen Morton, Alex Nester, Andrew O'Brien, Thomas L Ortel, Alexander Pine, Allyson Pishko, Mona Ranade, Amirali Salmasi, Jordan Schaefer, Eliot Williams, Geoffrey Wool, Theodore Wun, Sarah Montgomery, Jamie Nguyen, Deborah Freedman-Cass, Bailee Sliker
{"title":"癌症相关静脉血栓栓塞性疾病，2.2024 版，NCCN 肿瘤学临床实践指南。","authors":"Michael B Streiff, Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Tyler Buckner, Robert Diep, Kleber Yotsumoto Fertrin, Annemarie E Fogerty, Nicolas Gallastegui Crestani, Radhika Gangaraju, Cristhiam Rojas-Hernandez, Samuel Z Goldhaber, Ibrahim Ibrahim, Timothy Kubal, Andrew D Leavitt, Ming Lim, Janelle Mann, Simon Mantha, Colleen Morton, Alex Nester, Andrew O'Brien, Thomas L Ortel, Alexander Pine, Allyson Pishko, Mona Ranade, Amirali Salmasi, Jordan Schaefer, Eliot Williams, Geoffrey Wool, Theodore Wun, Sarah Montgomery, Jamie Nguyen, Deborah Freedman-Cass, Bailee Sliker","doi":"10.6004/jnccn.2024.0046","DOIUrl":null,"url":null,"abstract":"<p><p>The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary efforts. The NCCN panel is comprised of specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, and pharmacology. The content featured in this issue specifically addresses the evaluation and recommended treatment options outlined in the NCCN Guidelines for the diverse subtypes of cancer-associated VTE.</p>","PeriodicalId":17483,"journal":{"name":"Journal of the National Comprehensive Cancer Network","volume":"22 7","pages":"483-506"},"PeriodicalIF":14.8000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.\",\"authors\":\"Michael B Streiff, Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Tyler Buckner, Robert Diep, Kleber Yotsumoto Fertrin, Annemarie E Fogerty, Nicolas Gallastegui Crestani, Radhika Gangaraju, Cristhiam Rojas-Hernandez, Samuel Z Goldhaber, Ibrahim Ibrahim, Timothy Kubal, Andrew D Leavitt, Ming Lim, Janelle Mann, Simon Mantha, Colleen Morton, Alex Nester, Andrew O'Brien, Thomas L Ortel, Alexander Pine, Allyson Pishko, Mona Ranade, Amirali Salmasi, Jordan Schaefer, Eliot Williams, Geoffrey Wool, Theodore Wun, Sarah Montgomery, Jamie Nguyen, Deborah Freedman-Cass, Bailee Sliker\",\"doi\":\"10.6004/jnccn.2024.0046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary efforts. The NCCN panel is comprised of specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, and pharmacology. The content featured in this issue specifically addresses the evaluation and recommended treatment options outlined in the NCCN Guidelines for the diverse subtypes of cancer-associated VTE.</p>\",\"PeriodicalId\":17483,\"journal\":{\"name\":\"Journal of the National Comprehensive Cancer Network\",\"volume\":\"22 7\",\"pages\":\"483-506\"},\"PeriodicalIF\":14.8000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the National Comprehensive Cancer Network\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.6004/jnccn.2024.0046\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Comprehensive Cancer Network","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6004/jnccn.2024.0046","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary efforts. The NCCN panel is comprised of specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, and pharmacology. The content featured in this issue specifically addresses the evaluation and recommended treatment options outlined in the NCCN Guidelines for the diverse subtypes of cancer-associated VTE.
期刊介绍：
JNCCN—Journal of the National Comprehensive Cancer Network is a peer-reviewed medical journal read by over 25,000 oncologists and cancer care professionals nationwide. This indexed publication delivers the latest insights into best clinical practices, oncology health services research, and translational medicine. Notably, JNCCN provides updates on the NCCN Clinical Practice Guidelines in Oncology® (NCCN Guidelines®), review articles elaborating on guideline recommendations, health services research, and case reports that spotlight molecular insights in patient care.
Guided by its vision, JNCCN seeks to advance the mission of NCCN by serving as the primary resource for information on NCCN Guidelines®, innovation in translational medicine, and scientific studies related to oncology health services research. This encompasses quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship.
JNCCN boasts indexing by prominent databases such as MEDLINE/PubMed, Chemical Abstracts, Embase, EmCare, and Scopus, reinforcing its standing as a reputable source for comprehensive information in the field of oncology.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
